Bavarian Nordic receives $120M contract from U.S. government for smallpox/mpox vaccine

Bavarian Nordic has received a $120 million contract from BARDA to manufacture bulk smallpox/mpox vaccine, replenishing inventory used during the 2022 mpox outbreak. The contract includes $96 million for bulk product in 2023 and additional doses and services through 2025.

“The U.S. government's foresight enabled us last year to rapidly respond to the global mpox outbreak by converting readily available bulk product into final vaccine doses.”business.sherbrookerecord.com

• 1 source
• business.sherbrookerecord.comBavarian Nordic Receives USD 120 Million Contract for the Manufacturing of Smallpox and Mpox Vaccine from the U.S. GovernmentBavarian Nordic A/SAug 3, 2023

Summarized from public sources; check the original articles before acting on it.